Moderna
MRNA
#211
Rank
ยฃ81.07 B
Marketcap
ยฃ200.38
Share price
5.83%
Change (1 day)
964.48%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: ยฃ81.07 Billion

As of November 2026 Moderna has a market cap of ยฃ81.07 Billion. This makes Moderna the world's 211th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ81.07 B795.67%
2025ยฃ9.05 B-26.44%
2024ยฃ12.30 B-58.65%
2023ยฃ29.76 B-47.82%
2022ยฃ57.03 B-25.23%
2021ยฃ76.28 B151.54%
2020ยฃ30.32 B504.16%
2019ยฃ5.01 B26.92%
2018ยฃ3.95 B

End of Day market cap according to different sources

On Nov 8th, 2026 the market cap of Moderna was reported to be:

ยฃ75.59 Billion
by Nasdaq info icon info icon
ยฃ75.59 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ505.88 B 523.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ230.28 B 184.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ273.08 B 236.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
ยฃ0.42 B-99.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ2.21 B-97.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ0.62 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ15.62 B-80.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ5.16 B-93.63%๐Ÿ‡บ๐Ÿ‡ธ USA